Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.43 Million AUD | -2.03% |
| 2023 | -11.2 Million AUD | -170.32% |
| 2022 | -7.2 Million AUD | 47.44% |
| 2021 | -7.06 Million AUD | -20.26% |
| 2020 | -5.87 Million AUD | 14.4% |
| 2019 | -6.86 Million AUD | -12.49% |
| 2018 | -5.45 Million AUD | 21.79% |
| 2017 | -7.79 Million AUD | 3.76% |
| 2016 | -8.1 Million AUD | 15.88% |
| 2015 | -8.42 Million AUD | 2.42% |
| 2014 | -9.04 Million AUD | -5.52% |
| 2013 | -8.92 Million AUD | -97.6% |
| 2012 | -4.73 Million AUD | -542.95% |
| 2011 | 1.57 Million AUD | -84.81% |
| 2010 | -5.54 Million AUD | 344.61% |
| 2009 | -4.25 Million AUD | -145.9% |
| 2008 | 1.47 Million AUD | 1350.99% |
| 2007 | 158.62 Thousand AUD | 111.07% |
| 2006 | -4.27 Million AUD | 37.23% |
| 2005 | -6.21 Million AUD | 18.23% |
| 2004 | -7.02 Million AUD | -803.49% |
| 2003 | -841.51 Thousand AUD | 82.41% |
| 2002 | -2.68 Million AUD | -13569.88% |
| 2001 | 35.51 Thousand AUD | 101.41% |
| 2000 | -2.51 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -20.03% |
| 2024 Q4 | -5.47 Million AUD | 0.0% |
| 2024 Q2 | -4.88 Million AUD | 0.0% |
| 2023 FY | - AUD | -170.32% |
| 2023 Q2 | -5.06 Million AUD | 0.0% |
| 2023 Q4 | -4.23 Million AUD | 0.0% |
| 2022 FY | - AUD | 47.44% |
| 2022 Q4 | -3.94 Million AUD | -120.08% |
| 2022 Q1 | -1.8 Million AUD | 53.05% |
| 2022 Q2 | -4.75 Million AUD | -163.52% |
| 2022 Q3 | -1.79 Million AUD | 62.28% |
| 2021 Q3 | -1.78 Million AUD | 58.54% |
| 2021 Q2 | -4.3 Million AUD | 0.0% |
| 2021 Q4 | -3.84 Million AUD | -115.51% |
| 2021 FY | - AUD | -20.26% |
| 2020 FY | - AUD | 14.4% |
| 2020 Q2 | -2.94 Million AUD | 0.0% |
| 2020 Q4 | -3.94 Million AUD | 0.0% |
| 2019 FY | - AUD | -12.49% |
| 2019 Q4 | -3.27 Million AUD | 0.0% |
| 2019 Q2 | -3.07 Million AUD | 0.0% |
| 2018 Q4 | -2.82 Million AUD | 0.0% |
| 2018 FY | - AUD | 21.79% |
| 2018 Q2 | -3.27 Million AUD | 0.0% |
| 2017 Q2 | -3.91 Million AUD | 0.0% |
| 2017 Q4 | -3.7 Million AUD | 0.0% |
| 2017 FY | - AUD | 3.76% |
| 2016 FY | - AUD | 15.88% |
| 2016 Q4 | -4.22 Million AUD | 0.0% |
| 2016 Q2 | -3.88 Million AUD | 0.0% |
| 2015 Q4 | -4.08 Million AUD | 0.0% |
| 2015 FY | - AUD | 2.42% |
| 2015 Q2 | -5.54 Million AUD | 0.0% |
| 2014 Q4 | -4.73 Million AUD | 0.0% |
| 2014 FY | - AUD | -5.52% |
| 2014 Q2 | -5.13 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q4 | -5.33 Million AUD | 0.0% |
| 2013 FY | - AUD | -97.6% |
| 2013 Q2 | -3.59 Million AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | -542.95% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 FY | - AUD | -84.81% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 344.61% |
| 2009 FY | - AUD | -145.9% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | -14.35 Million AUD | -316.43% |
| 2008 FY | - AUD | 1350.99% |
| 2008 Q1 | 4.42 Million AUD | 149.16% |
| 2008 Q2 | 1.29 Million AUD | -70.8% |
| 2008 Q3 | 6.63 Million AUD | 413.69% |
| 2007 Q4 | -8.99 Million AUD | -312.04% |
| 2007 FY | - AUD | 111.07% |
| 2007 Q3 | 4.24 Million AUD | 440.83% |
| 2007 Q2 | -1.24 Million AUD | -145.93% |
| 2007 Q1 | 2.7 Million AUD | 119.52% |
| 2006 Q4 | -13.87 Million AUD | -640.11% |
| 2006 FY | - AUD | 37.23% |
| 2006 Q1 | 3.37 Million AUD | 118.48% |
| 2006 Q2 | -218.37 Thousand AUD | -106.47% |
| 2006 Q3 | 2.56 Million AUD | 1276.44% |
| 2005 Q3 | 3.55 Million AUD | 2409.12% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q4 | -18.26 Million AUD | -614.47% |
| 2005 FY | - AUD | 18.23% |
| 2005 Q2 | -153.78 Thousand AUD | -104.09% |
| 2004 FY | - AUD | -803.49% |
| 2003 FY | - AUD | 82.41% |
| 2002 FY | - AUD | -13569.88% |
| 2001 FY | - AUD | 101.41% |
| 2000 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 106.286% |
| BCAL Diagnostics Limited | -5.66 Million AUD | -101.713% |
| Genetic Signatures Limited | -20.33 Million AUD | 43.796% |
| Healius Limited | -298.09 Million AUD | 96.165% |
| Imagion Biosystems Limited | -13.69 Million AUD | 16.545% |
| Integral Diagnostics Limited | 12.33 Million AUD | 192.676% |
| INOVIQ Ltd | -6.63 Million AUD | -72.321% |
| Microba Life Sciences Limited | -22.8 Million AUD | 49.885% |
| Monash IVF Group Limited | 13.02 Million AUD | 187.76% |
| Rhythm Biosciences Limited | -6.79 Million AUD | -68.2% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 100.689% |